RxDoctor Payments Data

Khaled Abdel Hamid, MD

Allergy & Immunology · Saint Louis, MONPI 1679591572

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Blueprint Medicines Corporation at 37.3% of the total. That places this record below the midpoint for allergy & immunology clinicians in MO, where the typical reported total is $1,710.

$139in general payments, 2019–2025

Across 6 payments — averaging $23.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Blueprint Medicines Corporation$52
  • Pfizer$46
  • CSL Behring$23
  • Teva Pharmaceuticals USA, Inc.$19
$34,760in research payments, 2019–2025

Across 1 payment — averaging $34,760 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$35K

What the payments were for

  • Food & beverage$139100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$139 in reported general payments places this provider in the 10th percentile of 61 allergy & immunology providers in Missouri.

See all allergy & immunology providers in Missouri

Medicare billing

Part B allowed, 2024
$917,407
Medicare patients
347
Services billed
39,756

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HizentraImmun Glob G(Igg)/Pro/Iga 0-5044$216,215
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$13,799
Breo ElliptaFluticasone/Vilanterol25$11,650
Cromolyn Sodium13$8,728
Azelastine Hcl172$4,153
Epinephrine21$3,897
DuleraMometasone/Formoterol11$3,705
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate15$3,078
Azelastine-FluticasoneAzelastine/Fluticasone20$2,663
Fluticasone Propionate96$1,484
Levocetirizine Dihydrochloride109$1,446
Montelukast Sodium149$890
Albuterol Sulfate HfaAlbuterol Sulfate34$680
Levalbuterol Tartrate HfaLevalbuterol Tartrate11$605
Famotidine17$240

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
CSL BehringHizentra$23$216,21544 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 61 allergy & immunology providers in Missouri.

Other allergy & immunology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →